Do you require support on developing your project? The call for EHA research training programs is now open. Make sure to apply soon to be one of 20 scholars joining #EHACRTH , #TRTH , or #CBTH .

Learn more: eha.fyi/Research_Train…

The drug Voxelotor is to be available on the NHS, helping up to 4,000 patients in England with sickle cell disease, it has been announced.

Read the latest #BSHNews story here: ow.ly/mQpr50RE4OZ

Come and join us next Friday (24 May) for our BSH Paediatric SIG/PHTN Teaching Session
🕰️ 08:30–09:30
💻 Online via Zoom

Register here: ow.ly/uchm50RH8Fx

We are delivering a 6-part Global Antimicrobial Resistance webinar series with speakers from the UK and countries around the world. If you would like to learn more about webinar 3 - Antimicrobial Stewardship in Secondary Care, please click here ow.ly/X1xl50RazMp

Primary care pathways aimed at identifying patients with possible cancer should have a specific screening system for myeloma, according to new recommendations.

Read our latest #BSHNews story here: ow.ly/21i950RE4Gu

Scandinavian researchers have made a breakthrough in the search for universal donor blood, it has been announced.

Read the latest #BSHNews story here: ow.ly/kTPJ50RE4wC

2 weeks left to submit your abstract to the 19th #EHA -ASCAT-BSH - Haematology Annual Sickle Cell & Thalassaemia Conference. Browse this year's topics covering the latest developments in novel therapies, gene therapies, and more: eha.fyi/ASCAT2024

At the start of #MentalHealthWeek we're shining a light on our resources to help support our members in your career, especially if you're in the early stages

ow.ly/8hRr50RB6it

#BSH President Dr Sue Pavord discussing advancements across all sub specialties of Haematology at #HPCC24

A novel treatment for T-cell leukaemias and lymphomas is showing promise after success in research with mice, researchers have reported.

Read the latest #BSHNews story here: ow.ly/KHQz50RycM4

👋 We have arrived at the Haematology Patient and Carers Congress

Come and say hello to our friendly team on the #BSH stand

Huge congratulations to our Clinical Fellow Dr Hyun Park who has secured a BSH - Haematology Early-Stage Research (ESR) Start-up grant to continue his research in Sussex Life Sciences BSMS characterising Wnt signalling in normal haematopoiesis and AML. 👏👏👏

A coin-sized chip can directly isolate blood plasma from a tube of blood in just 30 minutes, making it quicker than the current multi-step centrifugation process, researchers have reported.

Read the latest #BSHNews story here: ow.ly/ztfv50RycEs

It's #InternationalThalassaemiaDay - take a look at some of our thalassaemia guidelines

ow.ly/Lax150ReRZl

b-s-h.org.uk/guidelines/gui…

Happy International Thalassaemia Day!

Today, we join hands with our friends & societies around the world to remember our angels lost & to raise awareness and the standards of care for managing #thalassaemia

Here’s to an exciting, healthier & happier future for all.

#teamukts

A portal for sharing, analysing and visualising paediatric cancer survivorship data is enabling doctors to improve understanding of the challenges faced by these patients.

Read the latest #BSHNews story here: ow.ly/U89Y50RycR3

Could changing the way we think about climate change be key to adapting and building emotional resilience in the face of uncertainty? In our latest Bulletin, Sergei Shubin takes lessons learnt from the COVID-19 pandemic applies them to the climate emergency: ow.ly/xjeU50Rg2Vl

ATTENTION : Calling all stakeholders in Haemaglobinopathies research and care!

MAY is the month of action, and there are two ASCAT deadlines you need to be aware of:

1️⃣ Abstract Submission by May 31st
2️⃣ Early Bird Registration by May 31st

ascatconferences.com

Reflecting on a wonderful week last week, we had a record number of attendees at the #BSH 24 #ASM

If that wasn't enough we have also reached a record number of members with over 3,000 members in the #BSH community

A new gene editing therapy for sickle cell disease and β-thalassaemia showed benefits for more than 90% of patients, according to the final results of the first clinical trials.

Read the latest #BSNews story here: ow.ly/vlgM50RtiHg